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Abstract 
Background: To compare the perinatal outcome 
between explained and unexplained (idiopathic) 
polyhydramnios. 
Methods: In this descriptive study, 50 women with 
singleton pregnancies with  idiopathic polyhydramnios, 
delivered in a period of one year, were compared with 45 
pregnant women with known causes of polyhydramnios. 
Outcome measures studied were preterm delivery (<37 
weeks gestation), low birth weight (<2.5 kg), macrosomia 
(>4.0 kg), malpresentations, APGAR score at 5 minutes <7, 
rate of caesarean section, neonatal hospitalization, 
congenital anomalies and perinatal death.  
Results: Incidence of polyhydramnios was found to be 
1.36%. In 52.63% of cases no cause of polyhydramnios was 
found, while 47.37% of cases were found to have 
underlying causes of polyhydramnios. There was a 
statistically significant increased incidence of preterm 
delivery (31%, p-value < 0.05), caesarean section (44.4%, p-
value<0.05), NICU admission (33%, p-value < 0.05), 
congenital anomalies (22%, p-Value < 0.05) and perinatal 
death (20%, p-value < 0.05) in explained polyhydramnios 
group as compared to unexplained polyhydramnios group. 
There was also an increased incidence of malpresentations 
(24.4%) and low APGAR score (33%) in explained 
polyhydramnios group. 
Conclusion: Antenatal diagnosis of polyhydramnios 
requires careful search for associated underlying maternal 
and fetal conditions. Idiopathic Polyhydramnios is not 
associated with adverse perinatal outcome. 
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Introduction 
    Amniotic fluid provides the fetus, a protective 
environment suitable for growth and development. 
Polyhydramnios (amniotic fluid more than 200 
ml),complicates approximately 1 to 3.5 % of 
pregnancies. It is defined as deepest vertical pool of 8 
cm or greater or an amniotic fluid index above 95th 
centile for gestational age.1-4 The definition of 
polyhydramnios also includes an Amniotic Fluid 
Index (AFI) of 24 cm or greater or a single deepest 
pocket (SDP) of greater than 8 cm. 5 Polyhydramnios 
can be divided into three groups: mild (amniotic fluid 
index 25-30 cm or SDP of 8 – 11 cm), moderate (AFI 30 
– 35 cm or SDP of 11 – 15 cm) and severe (AFI>35 cm 
or SDP of > 15 cm). 6,7  
     Polyhydramnios can occur as a result of variety of 
fetal, maternal and placental abnormalities. These 
include major congenital abnormalities, chromosomal 
aberrations, multiple gestations, maternal diabetes and 
Rh. isoimmunisation. In about 65% of cases, none of 
these can be identified (idiopathic polyhydramnios). 1 
Pregnancy complications, associated with 
polyhydramnios, include preterm delivery, pre-labour, 
rupture of membranes, abnormal fetal presentation, 
caesarean section, intrauterine demise and neonatal 
death.  
       Most cases of idiopathic or unexplained 
polyhydramnios are of mild variety and carry a low 
risk of undiagnosed anomalies which may not be 
detected in antenatal period. 1,8 It may be associated 
with fetal macrosomia  and an increased risk of 
delivery complications such as preterm labour and 
fetal mal-presentations.9-12 In one report, 
polyhydramnios with a normal fetus carried a 10 – 
20% risk of preterm birth and a 3 – 5% risk of fetal 
death. 5 On the other hand, explained polyhydramnios 
is associated with even higher rate of perinatal 
complications which are related to the underlying 
cause. Perinatal mortality is also higher in explained 
polyhydramnios. 
 
Patients and Methods 
      This descriptive study was carried out from 
January 2011 – December 2011, in DHQ Teaching 
Hospital, Rawalpindi. Ninety eight patients with 
polyhydramnios and more than 24 weeks of gestation 
were included in the study.  Amniotic fluid volume of 
these patients was assessed ultrasonographically using 
the 4-quadrant method. For the determination of AFI, 
the uterus was divided into four equal segments and 
the largest vertical pocket of fluid void of fetal parts or 
umbilical cord was measured in each quadrant. All 
four measurements were then added to calculate the 
index. Patients whose AFI was greater than 24 cm 
were diagnosed as having polyhydramnios. They were 
further classified as having mild (AFI 25 – 30cm), 
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moderate (AFI 30 – 35cm) and severe polyhydramnios 
(AFI > 35cm). These patients were advised to get their 
blood groups checked, detailed anomaly scan and 
whole day sugar profile to detect congenital anomalies 
and diabetes mellitus. Those found to be Rh negative 
were checked for Rh antibody titre. The patients were 
followed up fortnightly to identify any cause of 
polyhydramnios. The patients were then divided into 
two groups. Group ‘A’ included patients with no 
detectable cause of polyhydramnios (unexplained or 
idiopathic polyhydramnios). The patients having 
congenital anomalies, multiple gestation, diabetes 
mellitus, and Rh.isoimmunisation were included in 
Group ‘B’ (explained polyhydramnios).  
     Apgar score of baby was noted immediately after 
delivery and then at five minutes. The record of any 
detectable congenital anomalies and any resuscitation 
carried out on the baby was made. Outcome measures 
studied were macrosomia (>4.0 kg), low birth-weight 
(<2.5kg), pre-term delivery (<37 weeks), 
malpresentation at delivery, caesarean section rate, 
perinatal death, any detectable congenital anomalies,  
Apgar score at five minutes <7 and admission to 
Neonatal Intensive Care Unit (NICU). Statistical 
significance was taken as p< 0.05. 
 
Results 
    Total deliveries conducted during the study  period 
were 7184. Amongst them, 98 patients (1.36%) were 
found to have polyhydramnios. Three patients were 
lost to follow up. Idiopathic polyhydramnios was 
detected in 50 patients (52.63%) while 45 patients 
(47.37%) had underlying causes of polyhydramnios 
(explained polyhydramnios). Diabetes mellitus 
(44.44%)  was the commonest cause in explained 
polyhydramnios (Table 1). Majority (71.1%) had mild 
polyhydramnios(Table 2).No case of Rh. 
isoimmunisation was reported.  
     There was an increase in the incidence of preterm 
delivery and caesarean section in Group ‘B’ (explained 
polyhydramnios) which was almost double than that 
of Group ’A’ (31 % vs 14%) & (44.40% vs 24%) 
respectively (p value <0.05 statistically significant) 
(Table 3). The rate of low birth-weight was found to be 
more common in Group ‘A’ (idiopathic 
polyhydramnios) as compared to Group ‘B’ (explained 
polyhydramnios) (20% vs 13.30%) but was not 
statistically significant (Table 3).  
     There was statistically significant increase in NICU 
admission and perinatal death in Group ‘B’ as 
compared to Group ’A’ (33% vs 12%) & (20% vs 4%) 
respectively (p value < 0.05). There was no case of 
detectable congenital anomalies in Group ‘A’ while 
22.22% cases in Group ‘B’ had congenital 
abnormalities in the babies (p Value < 0.05). There 
were 2 cases (4%) of macrosomia in each group. 
Malpresentation and low APGAR score were found to 
be more common in Group ‘B’ as compared to Group 
‘A’ (24.40% vs 14%) & (13.30% vs 6%) respectively but 
was not statistically significant. 
Table 1: Causes of Explained Polyhydramnios (n=45) 
Cause No(%) 
Diabetes Mellitus 20(44.44%) 
Multiple gestations 15(33.33%) 
Congenital abnormalities 10(22.22%) 
 
Table 2: Severity of Polyhydramnios 
 Group A-
Unexplained 
Polyhydramnios  
( n=50) 
Group B- 
Explained 
Polyhydraminos 
(n=45) 
Mild 42 (84%) 32 ( 71.1%) 
Moderate 6(12%) 8(17.77%) 
Severe  2(4%) 5(11.1%) 
  
Table 3: Maternal Complications in explained 
and unexplained  Polyhydramnios 
Outcome 
measures 
Group 
A (n=50) 
No (%) 
Group B 
(n=45) 
No (%) 
p-value 
Malpresentation 7(14) 11(24.4) >0.05 
Caesarean  
section  
12(24) 20(44.4) <0.05 
Pre-term delivery 
(<37 weeks) 
7(14) 14(31) <0.05 
p-value <0.05 significant ; p-value >0.05 Not significant  
 
Discussion 
     Pregnancies complicated by polyhydramnios are 
high risk and need to be thoroughly investigated. In 
cases where polyhydramnios is of mild to moderate 
degree and no cause is found in the mother as well as 
in fetus, perinatal outcome is good. While if there are 
serious congenital abnormalities in the fetus or  
polyhydramnios is severe, it results in maternal 
morbidity and perinatal mortality.4, 13  
    Cases of polyhydramnios in 3rd trimester, where no 
fetal congenital anomalies are detected on ultrasound,  
maternal and fetal morbidity and mortality can occur 
due to excessive abdominal distention, sudden 
premature rupture of membrane, placental abruption, 
cord prolapse, fetal malpresentation, preterm labor, 
postpartum hemorrhage and high risk of operative 
deliveries. 14 
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Table 4: Perinatal complications in explained 
and unexplained polyhydramnios 
Outcome measures Group A 
(n=50) 
No(%) 
Group B 
(n=45) 
No (%) 
p-
value 
Macrosomia(>4.0 kg) 2(4) 2(4.44) >0.05 
Low birth weight 
(<2.5 kg) 
10(20) 6 (13.3) >0.05 
 5 minutes A/S <7 3 (6) 6(13.3) >0.05 
Neonatal ICU 
admission 
6(12) 15(33) <0.05 
Congenital 
anomalies 
0(0) 10 ( 22.22) <0.05 
Perinatal death 2(4) 99(20) <0.05 
p-value < 0.05 significant ; p-value >0.05 not significant  
     The precise incidence of associated perinatal 
outcomes in such cases is unclear because of variation 
in definition of polyhydramnios, subjective impression 
as well as inter-observer variations in quantitative 
measurement of deepest vertical pocket. 9 
     Neural tube defects are detectable by ultrasound 
examination in first and second trimester. Structural 
abnormalities like ventricular septal defects and 
anterior abdominal wall defects can be easily 
diagnosed by mid trimester scan. If early diagnosis is 
made, maternal morbidity can be reduced by offering 
termination of pregnancy at an earlier gestation when 
it is psychologically and physically less traumatic to 
the mother. It also avoids serious presentations of 
polyhydramnios and signifies the importance of 
ultrasound examination at 18-20 weeks. 4 
     Diabetes screening should be done in all cases of 
polyhydramnios to detect underlying impaired 
glucose levels.Twin pregnancies should also be 
considered as high risk and looked for development of 
polyhydramnios. A study showed an incidence of 
polyhydramnios and idiopathic polyhydramnios of 
4.80% & 67% respectively. 1 In a Pakistani study no 
maternal and fetal cause of polyhydramnios was 
found in 50% of cases. 4 The present study showed an 
increased incidence of preterm delivery, 
malpresentations, caesarean section, admission in 
neonatal intensive care unit, congenital anomalies and 
perinatal death in explained polyhydramnios group as 
compared to group of idiopathic polyhydramnios. The 
increase in caesarean section rate is due to increased 
incidence of malpresentations and fetal distress in 
cases of explained polyhydramnios. 
     Although many authors found an increased 
frequency of both maternal and fetal complications in 
cases of polyhydramnios, this does not necessarily 
hold true for idiopathic polyhydramnios. In many 
studies, polyhydramnios was found to be associated 
with higher rate of both maternal and perinatal 
complications and also found an increased incidence 
of pre-term delivery in patients with polyhydramnios. 
However, neither of these studies was specifically 
related to idiopathic polyhydramnios. 1  Various 
studies concluded that it is the underlying cause of 
polyhydramnios rather than the relative excess of 
amniotic fluid which is responsible for maternal 
complications and perinatal mortality. 4, 14 
 
Conclusion 
Explained polyhydramnios is associated with higher 
rates of perinatal complications and deaths while 
idiopathic polyhydramnios does not seem to have 
adverse perinatal outcome. Even then, pregnancies 
with idiopathic polyhydramnios should be considered 
as high risk and should be managed in high risk 
clinics. 
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